Rigel Pharmaceuticals (RI2.STU) Q2 2026 Earnings

5MayConfirmed
Q1 2026
Q2 2026
0.38
4.14
7.9
11.66

Details

Expected EPS
0.67863791614
Actual EPS
0.3754916
Surprise EPS
-0.3
Surprise Percent
+44.67%

Description

Rigel Pharmaceuticals (RI2.STU) has reported earnings of 0.3754916 per share for Q2 2026.

0 Comments

Share your thoughts